Polyrizon Ltd. Ordinary Shares
About
Polyrizon Ltd. Ordinary Shares (NASDAQ:PLRZ) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 27 2026
Polyrizon Announces Filing of European Patent Application for Its Breakthrough Drug Delivery Platform
Apr 8 2026
Polyrizon Ltd. Announces Closing of $3.5 Million Registered Direct and Private Placements
Apr 7 2026
Polyrizon Ltd. Announces $3.5 Million Registered Direct Offering and Private Placement
Mar 26 2026
Polyrizon Provides 2025 and Recent Highlights
Mar 25 2026
Polyrizon Ltd. Files Annual Report on Form 20-F for the Fiscal Year Ended December 31, 2025
Financials
Revenue
$0
Market Cap
$19.95 M
EPS
-4.90